- £4.74bn
- £5.34bn
- £2.20bn
- 96
- 31
- 55
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,873 | 1,825 | 1,866 | 2,049 | 2,196 |
Cost of Revenue | |||||
Gross Profit | 814 | 816 | 862 | 938 | 1,014 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,669 | 1,598 | 1,616 | 1,751 | 1,877 |
Operating Profit | 204 | 227 | 251 | 298 | 319 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 189 | 214 | 245 | 285 | 302 |
Provision for Income Taxes | |||||
Net Income After Taxes | 153 | 170 | 196 | 226 | 237 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 156 | 170 | 196 | 226 | 237 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 156 | 170 | 196 | 226 | 237 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.795 | 0.814 | 0.945 | 1.07 | 1.19 |
Dividends per Share |